Resultados globales: 2 registros encontrados en 0.01 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
14 p, 1.2 MB Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology / Suárez Calvet, Marc (Ludwig-Maximilians-Universität München) ; Morenas-Rodríguez, Estrella (Institut d'Investigació Biomèdica Sant Pau) ; Kleinberger, Gernot (Ludwig-Maximilians-Universität München) ; Schlepckow, Kai (German Center for Neurodegenerative Diseases (DZNE) Munich) ; Araque Caballero, Miguel Ángel (Ludwig-Maximilians-Universität München) ; Franzmeier, Nicolai (Ludwig-Maximilians-Universität München) ; Capell, Anja (Ludwig-Maximilians-Universität München) ; Fellerer, Katrin (Ludwig-Maximilians-Universität München) ; Nuscher, Brigitte (Ludwig-Maximilians-Universität München) ; Eren, Erden (Ludwig-Maximilians-Universität München) ; Levin, Johannes (German Center for Neurodegenerative Diseases (DZNE) Munich) ; Deming, Yuetiva (Washington University School of Medicine) ; Piccio, Laura (Washington University School of Medicine) ; Karch, Celeste M. (Washington University School of Medicine) ; Cruchaga, Carlos (Washington University School of Medicine) ; Shaw, Leslie M. (University of Pennsylvania) ; Trojanowski, John Q.. (University of Pennsylvania) ; Weiner, Michael (University of California at San Francisco) ; Ewers, Michael (Ludwig-Maximilians-Universität München) ; Haass, Christian (Ludwig-Maximilians-Universität München) ; Universitat Autònoma de Barcelona
TREM2 is a transmembrane receptor that is predominantly expressed by microglia in the central nervous system. Rare variants in the TREM2 gene increase the risk for late-onset Alzheimer's disease (AD). [...]
2019 - 10.1186/s13024-018-0301-5
Molecular neurodegeneration, Vol. 14 (january 2019)  
2.
21 p, 965.2 KB CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline / Suárez-Calvet, Marc (Ludwig-Maximilians-Universität München) ; Capell, Anja (Ludwig-Maximilians-Universität München) ; Araque Caballero, Miguel Ángel (Ludwig-Maximilians-Universität München) ; Morenas-Rodríguez, Estrella (Universitat Autònoma de Barcelona) ; Fellerer, Katrin (Ludwig-Maximilians-Universität München) ; Franzmeier, Nicolai (Ludwig-Maximilians-Universität München) ; Kleinberger, Gernot (Munich Cluster for Systems Neurology (SyNergy)) ; Eren, Erden (Dokuz Eylul University, Turkey) ; Deming, Yuetiva (Washington University School of Medicine) ; Piccio, Laura (Washington University School of Medicine) ; Karch, Celeste M. (Washington University School of Medicine) ; Cruchaga, Carlos (Washington University School of Medicine) ; Paumier, Katrina (Washington University School of Medicine) ; Bateman, Randall J. (Washington University School of Medicine) ; Fagan, Anne M. (Washington University School of Medicine) ; Morris, John C. (Washington University School of Medicine) ; Levin, Johannes (Ludwig-Maximilians-Universität München) ; Danek, Adrian (Ludwig-Maximilians-Universität München) ; Jucker, Mathias (University of Tübingen) ; Masters, Colin L. (University of Melbourne) ; Rossor, Martin N. (UCL Institute of Neurology (Regne Unit)) ; Ringman, John M. (University of Southern California) ; Shaw, Leslie M. (University of Pennsylvania) ; Trojanowski, John Q.. (University of Pennsylvania) ; Weiner, Michael (University of California at San Francisco) ; Ewers, Michael (Ludwig-Maximilians-Universität München) ; Haass, Christian (Munich Cluster for Systems Neurology (SyNergy))
Progranulin (PGRN) is predominantly expressed by microglia in the brain, and genetic and experimental evidence suggests a critical role in Alzheimer's disease (AD). We asked whether expression is changed in a disease severity-specific manner in . [...]
2018 - 10.15252/emmm.201809712
EMBO Molecular Medicine, Vol. 10 (november 2018)  

Vea también: autores con nombres similares
1 Fellerer, K.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.